Home Use Consultation Guidance
What is self-managed abortion?
Self‐administered medical abortion as the act of a woman taking mifepristone, or misoprostol, or both, (i.e. inserting the pill(s) in her mouth or vagina), on her own, without the physical supervision of a healthcare provider, during at least one stage of the drug regimen. This can take place with written guidance and after a remote telemedicine appointment over the phone or video call.
Why should we make the measure permanent?
There are countless compelling reasons why someone might choose to self-administer an abortion, even outside of the context of a public health crisis – victims of domestic abuse, women in precarious employment, shift work or on zero hours contracts, may be unable to take the time off work needed for in-clinic consultations. Disabled women are disadvantages by the need to travel as well as those in rural communities. These measures level the playing field in these cases.
As a society, we must trust that people will make the best decisions for themselves and their families.
Facts about self-managed abortions
- Women report finding self-managed abortion with approved medication safe, effective and convenient.
- Major medical complications have dropped by two thirds
- Waiting times for abortion has halved and the duration of pregnancy at which abortions occur has reduced from over 8 weeks to under 7 weeks
- The lower gestational age makes the procedure safer
- Ensures access to the most vulnerable – women in coercive or abusive relationships, those on low-incomes may be unable to afford travel and childcare costs. Those who live in rural or remote areas may not be able to reach their nearest abortion clinic, which could be many miles away.
The details of the consultation can be found here: http://bit.ly/UKGovHomeUseConsultation
Abortion Rights has an email your MP tool to let your MP know how you feel here http://bit.ly/KeepTelemedicineEmailYourMP
The consultation closes on 26 February 2021.
Abortion Rights is the only member-led pro-choice campaign in the UK www.abortionrights.org.uk
The consultation should take between 30-45 minutes to complete. We know anti-choice organisations are encouraging their supporters to participate. For a question by question guide see below.
Question: Do you consider that the temporary measure has had an impact on the provision of abortion services for women and girls accessing these services with particular regard to safety?
- Yes, it has had a positive impact
The provision of abortion pills for home administration is a long overdue and progressive step forward. One which is in line with modern medicine and clinically safe.
Data provided by the British Pregnancy Advisory Service (BPAS) shows a reduction in the risk of medical abortions across the board, with the risk of major complications dropping by two-thirds, and the risk of continuing pregnancy, which would require further treatment, down by almost three-quarters.[1]
The fact that abortions can be obtained quicker and at a lower gestational age removes complications and makes the procedure safer.
International scientific evidence[2] clearly demonstrates the safety and clinical appropriateness of home administration. Medical abortion is recommended by the World Health Organisation, with both abortion pills included within their list of essential medicines that should be available in every country.
Question: Do you consider that the temporary measure has had an impact on the provision of abortion services for women and girls accessing these services with particular regard to accessibility?
- Yes, it has had a positive impact
In terms of access, it is undoubtedly the case that permitting home administration for both pills increases women’s access to abortion healthcare. Home administration removes real and significant barriers which women have prevented women accessing services in a timely and appropriate manner in the past.
Abortion Rights considers that the following barriers will be lessened by home administration:
- Waiting times – data produced by the Royal College of Obstetricians and Gynaecologists show that the average waiting time for an abortion has halved, reducing to 4.5 days.
- The requirement to travel for services – some women have been known to pass their abortions on the bus home rather than be in the comfort of their own home. In a 2017 study a woman gave her experience, “when I was on the bus I could feel that I was bleeding a lot […] I was really tired. I was just kind of, y’know: ‘I’ve spent 45 minutes on a bus for a two-minute appointment..?’[3]
- Cost of travel – this has a disproportionate impact on rural and disabled women.
- Cost of childcare – the majority of abortions are performed on women who are already parents[4]
- Time off work – this can affect income, and if relying on shifts or on zero hours contracts, could affect future income.
- Domestic violence – A 2018 study, which looked at barriers to abortion access highlighted women who couldn’t access abortion services for fear of the repercussions.[5]
Question: Do you consider that the temporary measure has had an impact on the provision of abortion services for women and girls accessing these services with particular regard to privacy and confidentiality of access?
a) Yes, it has had a positive impact
As mentioned earlier, the ability to have an abortion consultation in a safe and private space enables women in domestic abuse situations more control and access.
Being at home while managing prevents the abortion passing on the way home and is generally more comfortable and private.
Those with concerns about any kind of coercion can more easily arrange a teleconsultation and avoid travel, time away from their daily routine or expenses that could limit their opportunity to access healthcare.
Question: Do you consider that the temporary measure has had an impact on the provision of abortion services for those providing services? This might include greater workforce flexibility, efficiency of service delivery, value for money etc.
- Yes, it has had a positive impact
A study into abortion provision in England and Wales concluded that the recent changes “further builds a strong case for changing policies to match the evidence base”, concluding that shifting early medical abortion services to GP clinics would increase the number of trained health professionals that perform simple abortion procedures, freeing up specialists for more urgent, complicated cases, such as those seeking abortion in later in pregnancy.[6]
Question: Have other NHS services been affected by the temporary measure?
Yes [please provide details of which services]
In England and Wales in 2019, 82% of abortions were under 10 weeks. The Royal College of Obstetricians and Gynaecologists have stated that, “This has significantly reduced the need for hospital admission and the risk of women suffering complications associated with surgical procedures. This simple adjustment to service delivery also means that precious NHS resources are saved by reducing the number of visits that a woman has to make to a clinic to obtain her medication”.[7]
Integrating an early medical abortion service could affect the work of GP clinics, but the task-shifting proposals outlined in the study mentioned above provide significant efficiencies.
Question: What information do you consider should be given to women around the risks of accessing pills under the temporary measure if their pregnancy may potentially be over 10 weeks gestation?
On 21st March 2020, in response to the risk to abortion providers and people seeking abortion care, the Royal College of Obstetricians and Gynaecologists (RCOG), the Royal College of Midwives, the Faculty of Sexual and Reproductive Healthcare, and the British Society of Abortion Care Providers produced clinical guidance for the provision of abortion care during the COVID-19 pandemic.
This guidance recommends a pathway for the provision of Early Medical Abortion with a focus on telemedicine to minimise risk and maintain provision of abortion as a time-sensitive, essential service. Specifically, it recommends: Providing remote consultation via video or telephone call and limiting in-clinic care. Limiting ultrasound provision to only where necessary – such as symptoms or history of ectopic pregnancy, the presence of an IUD or IUS, or uncertainty about the date of last menstrual period.
Question: Outside of the pandemic do you consider there are benefits or disadvantages in relation to safeguarding and women’s safety in requiring them to make at least one visit to a service to be assessed by a clinician?
- Yes, disadvantages
Abortion Rights believes that the approach should be patient-led. If they wish to attend a clinic and be seen in person, this should be available. The RCOG guidance mentioned above makes recommendations on safeguarding for telemedicine. Recent experience and evidence from numerous studies show it is not necessary and therefore should not be enforced.
Question: To what extent do you consider making permanent home use of both pills could have a differential impact on groups of people or communities?
For example, what is the impact of being able to take both pills for EMA at home on people with a disability or on people from different ethnic or religious backgrounds?
Abortion Rights believes that continuing the current arrangements for early medical abortion at home improves the service for all women, by making it more accessible. As set out above, travel is a particular barrier to women accessing services.
This burden is increased exponentially for disabled women who have specific access and travel needs. This can result in disabled women relying on the help of others and the confidentiality of their healthcare needs can therefore be compromised. The current arrangement removes this barrier and means abortion services for disabled women are more accessible and more confidential. Further, the current system, as referenced above increases access for women living in an abusive relationship.
Due to the patriarchal society in which we live, abortion is too often still stigmatised and used to reinforce gender stereotypes of women and sexual relationships. In particular, a barrier to accessing abortion services can be due to religious and cultural matters.
Again, the current systems helps to break down some of these barriers meaning that services can be accessed from home and are therefore more straightforward and private. The same point applies to women of limited immigration status who may otherwise be reluctant to seek services.
Question: To what extent do you consider that making permanent home use of both pills for EMA would increase or reduce the difference in access to abortion for women from more deprived backgrounds or between geographical areas with different levels of disadvantage?
Abortion Rights are firmly of the view that the current arrangements reduce socio-economic inequalities which currently exist in the provision of abortion services.
As set out above travel, cost of travel, cost of childcare and time off work all mean that women in lower socio-economic groups have to overcome many barriers to access abortion services. Too often, abortion services are not only determined by your postcode but also by your class and your ability to pay.
This is particularly the case in the current economic climate where jobs are insecure and the use of temporary and zero hours contracts are on the increase. Women working in these types of roles cannot afford to turn down work in order to attend multiple appointments to access abortion services. Not only will turning down work result in a reduction in their income, it also has the potential to reduce their earning potential significantly. In the current economy it is more of an employers’ market that ever before. Zero hours contracts and temporary contracts allow employers to hire and fire employees with impunity.
If a woman, working on a zero hours contract, requires multiple days off to attend appointments, and then further time off to undergo the abortion procedure, she may well find that she is not subsequently offered any shifts, or that there is a significant reduction in her shifts.
The current system would prevent all of this, as it cuts out the need for multiple appointments and allows women to take the medications at a time which is suitable for them in line with their lives and commitments.
We are in agreement with Doctors for Choice in their statement that “attempts to revoke temporary regulatory changes would therefore disproportionately affect women of lower socio-economic status”.[8]
Question: Should the temporary measure enabling home use of both pills for EMA [select one of the below]
a) Become a permanent measure?
Yes, for all the reasons and evidence mentioned above.
Patients have said they are happy with the current regulations. Data from MSI Reproductive Choices UK shows that overall 98.2% of those who responded to satisfaction surveys reported that their experience was either “very good” or “good”.[9]
The changes are not just better and safer for women, they level the playing field and make our NHS more efficient.
Question: Have you any other comments you wish to make about whether to make home use of both pills for EMA a permanent measure?
You can add your own comments or experience.
[1] https://www.bpas.org/media/3385/bpas-pills-by-post-service.pdf
[2]Acta Obstet Gynecol Scand. 2014 Jul;93(7):647-53. doi: 10.1111/aogs.12398. Epub 2014 May 23. Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation. Løkeland M, Iversen OE, Engeland A, Økland I, Bjørge L. Free full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670695/
[3] Purcell, C. , Cameron, S., Lawton, J., Glasier, A. and Harden, J. (2017) Self-management of first trimester medical termination of pregnancy: a qualitative study of women’s experiences. BJOG: An International Journal of Obstetrics and Gynaecology, 124(13), pp. 2001-2008. (doi: 10.1111/1471- 0528.14690) (PMID:28421651) (PMCID:PMC5724679) http://eprints.gla.ac.uk/140042/
[4] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/891405/abortion-statistics-commentary-2019.pdf
[5] Aiken, A. R. A., Guthrie, K. A., Schellekens, M., Trussell, J., Gomperts, R. (2018). Barriers to accessing abortion services and perspectives on using mifepristone and misoprostol at home in Great Britain. Contraception, 97, 177-183
[6] Systematic review of early abortion services in low- and middle-income country primary care: potential for reverse innovation and application in the UK context Jacy Zhou, Rebecca Blaylock & Matthew Harris: Globalization and Health volume 16, Article number: 91 (2020) https://link.springer.com/article/10.1186/s12992-020-00613-z
[7] RCOG Better for women – improving the health and wellbeing of girls and women – December 2019 https://www.rcog.org.uk/globalassets/documents/news/campaigns-andopinions/better-for-women/better-for-women-full-report.pdf
[8] https://www.doctorsforchoiceuk.com/telemedicine
[9] https://www.medrxiv.org/content/10.1101/2020.11.11.20229377v2